Acer Therapeutics (ACER) Short Interest Ratio & Short Volume → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free ACER Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Acer Therapeutics Short Interest DataCurrent Short Volume524,900 sharesPrevious Short Volume493,600 sharesChange Vs. Previous Month+6.34%Dollar Volume Sold Short$441,020.98Short Interest Ratio / Days to Cover0.2Last Record DateOctober 31, 2023Outstanding Shares24,460,000 sharesFloat Size3,810,000 sharesShort Percent of Float13.78%Today's Trading Volume574,600 sharesAverage Trading Volume0 sharesToday's Volume Vs. Average∞ Short Selling Acer Therapeutics ? Sign up to receive the latest short interest report for Acer Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatACER Short Interest Over TimeACER Days to Cover Over TimeACER Percentage of Float Shorted Over Time Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). Acer Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2023524,900 shares $441,020.98 +6.3%13.8%0.2 $0.84 10/15/2023493,600 shares $375,136.00 -6.7%N/A0.2 $0.76 9/30/2023529,100 shares $431,216.50 -41.1%N/A0.2 $0.82 9/15/2023898,100 shares $776,138.02 +25.2%N/A0.4 $0.86 8/31/2023717,600 shares $918,528.00 -20.7%N/A0.3 $1.28 8/15/2023905,400 shares $693,083.70 +2.4%N/A6.1 $0.77 Get the Latest News and Ratings for ACER and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acer Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/2023884,100 shares $769,167.00 -2.7%N/A5.3 $0.87 7/15/2023908,200 shares $735,642.00 +1.3%N/A5.1 $0.81 6/30/2023896,400 shares $827,735.76 +14.7%N/A4.5 $0.92 6/15/2023781,500 shares $681,468.00 -3.7%N/A3.6 $0.87 5/31/2023811,900 shares $722,591.00 -18.4%N/A2.3 $0.89 5/15/2023994,500 shares $751,742.55 -9.6%N/A3.2 $0.76 4/30/20231,100,000 shares $965,360.00 -6.8%N/A3.6 $0.88 4/15/20231,180,000 shares $1.35 million -7.1%N/A3.6 $1.14 3/31/20231,270,000 shares $963,295.00 +275.5%N/A3 $0.76 3/15/2023338,200 shares $541,120.00 +14.4%N/A0.6 $1.60 2/28/2023295,600 shares $600,068.00 +3.4%N/A0.5 $2.03 2/15/2023285,800 shares $597,322.00 -42.6%N/A0.5 $2.09 1/31/2023498,300 shares $1.16 million +85.7%N/A0.8 $2.32 1/15/2023268,400 shares $805,200.00 -36.7%2.1%0.5 $3.00 12/30/2022424,300 shares $1.06 million -35.5%3.3%0.9 $2.51 12/15/2022657,800 shares $2.12 million +932.7%5.1%1.8 $3.22 11/30/202263,700 shares $80,899.00 +14.8%0.5%0.6 $1.27 11/15/202255,500 shares $67,155.00 -35.5%0.4%0.8 $1.21 10/31/202286,100 shares $109,347.00 +44.5%0.6%0.9 $1.27 10/15/202259,600 shares $72,712.00 -23.3%0.4%0.6 $1.22 9/30/202277,700 shares $108,003.00 -2.0%0.6%0.8 $1.39 9/15/202279,300 shares $118,157.00 +19.3%0.6%0.7 $1.49 8/31/202266,500 shares $89,775.00 -18.8%0.5%0.5 $1.35 8/15/202281,900 shares $124,488.00 -49.2%2.2%0.6 $1.52 7/31/2022161,300 shares $225,061.89 +7.0%4.2%1.1 $1.40 7/15/2022150,700 shares $231,188.87 -7.6%4.0%1 $1.53 6/30/2022163,000 shares $205,380.00 +49.3%4.3%0.9 $1.26 6/15/2022109,200 shares $197,652.00 -24.6%2.9%0.2 $1.81 5/31/2022144,900 shares $346,311.00 -41.0%1.1%0.3 $2.39 5/15/2022245,600 shares $476,464.00 +313.5%1.9%0.5 $1.94 4/30/202259,400 shares $122,364.00 -14.5%0.5%0.1 $2.06 4/15/202269,500 shares $159,850.00 +58.7%0.5%0.2 $2.30 3/31/202243,800 shares $127,020.00 -51.2%0.4%0.1 $2.90 3/15/202289,700 shares $211,692.00 -46.9%0.7%1.6 $2.36“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). ACER Short Interest - Frequently Asked Questions What is Acer Therapeutics' current short interest? Short interest is the volume of Acer Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 524,900 shares of ACER short. 13.78% of Acer Therapeutics' shares are currently sold short. Learn More on Acer Therapeutics' current short interest. What is a good short interest percentage for Acer Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.78% of Acer Therapeutics' floating shares are currently sold short. Is Acer Therapeutics' short interest increasing or decreasing? Acer Therapeutics saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 524,900 shares, an increase of 6.3% from the previous total of 493,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Acer Therapeutics' float size? Acer Therapeutics currently has issued a total of 24,460,000 shares. Some of Acer Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Acer Therapeutics currently has a public float of 3,810,000 shares. How does Acer Therapeutics' short interest compare to its competitors? 13.78% of Acer Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Acer Therapeutics: Context Therapeutics Inc. (0.29%), Grifols, S.A. (2.57%), LAVA Therapeutics (1.37%), Mainz Biomed (2.30%), NLS Pharmaceutics Ltd. (0.34%), Pharvaris (0.87%), Tiziana Life Sciences Ltd (0.25%), American Oncology Network, Inc. (0.83%), Concord Medical Services Holdings Limited (0.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($9.07 billion), T-Mobile US, Inc. ($3.71 billion), Charter Communications, Inc. ($3.51 billion), Occidental Petroleum Co. ($2.81 billion), Lululemon Athletica Inc. ($2.35 billion), Tractor Supply ($2.26 billion), Coinbase Global, Inc. ($1.88 billion), Rivian Automotive, Inc. ($1.71 billion), Celsius Holdings, Inc. ($1.67 billion), and Newmont Co. ($1.66 billion). View all of the most shorted stocks. What does it mean to sell short Acer Therapeutics stock? Short selling ACER is an investing strategy that aims to generate trading profit from Acer Therapeutics as its price is falling. ACER shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Acer Therapeutics? A short squeeze for Acer Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ACER, which in turn drives the price of the stock up even further. How often is Acer Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACER, twice per month. The most recent reporting period available is October, 31 2023. More Short Interest Resources from MarketBeat Related Companies: CNTX Short Squeeze GRFS Short Squeeze LVTX Short Squeeze MYNZ Short Squeeze NLSP Short Squeeze PHVS Short Squeeze TLSA Short Squeeze ATNFW Short Squeeze ACONW Short Squeeze AIMDW Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ACER) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders